Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacogenomic Testing”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Not applicableStudy completedNCT03749629
What this trial is testing

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 201
Early research (Phase 1)Study completedNCT05413551
What this trial is testing

Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention

Who this might be right for
Tuberculosis InfectionIsoniazid Adverse Reaction
Stanford University 73
Not applicableUnknownNCT05053815
What this trial is testing

Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Who this might be right for
PharmacogenomicsPolypharmacy
Tabula Rasa HealthCare 1,500
Not applicableStudy completedNCT04889014
What this trial is testing

Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum

Who this might be right for
Healthy
University of Arizona 233
Not applicableWithdrawnNCT00593905
What this trial is testing

Pharmacogenomics in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionPAH WHO Group I
West Penn Allegheny Health System
Not applicableLooking for participantsNCT02738047
What this trial is testing

Reduction of Adverse Drug Events and Readmissions

Who this might be right for
Pharmacogenomic Testing for Medication Management
ClinLogic LLC 280,000
Not applicableStudy completedNCT00830973
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Who this might be right for
Breast NeoplasmsTamoxifen
Medco Health Solutions, Inc. 184
Post-approval studies (Phase 4)Ended earlyNCT03537547
What this trial is testing

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepressionDepressive Disorder+2 more
Washington University School of Medicine 6
Not applicableStudy completedNCT00812149
What this trial is testing

Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3

Who this might be right for
Thyroid DiseaseHealthy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 86
Not applicableStudy completedNCT04923204
What this trial is testing

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Who this might be right for
Bipolar Disorder
AB Biotics, SA 76
Not applicableStudy completedNCT05504135
What this trial is testing

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

Who this might be right for
Pre-emptive Pharmacogenomics
Nalagenetics Pte Ltd 222
Not applicableStudy completedNCT06748040
What this trial is testing

Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy

Who this might be right for
Chronic Kidney DiseaseHypertension
Duke University 1,874
Post-approval studies (Phase 4)Study completedNCT02794844
What this trial is testing

Implementation of PPI Medication PGX Testing

Who this might be right for
Gastroesophageal Reflux
Nemours Children's Clinic 28
Testing effectiveness (Phase 2)Looking for participantsNCT05725200
What this trial is testing

Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Oslo University Hospital 40
Not applicableLooking for participantsNCT06489041
What this trial is testing

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Who this might be right for
CancerGastrointestinal Cancer
Wake Forest University Health Sciences 120
Post-approval studies (Phase 4)Study completedNCT01778907
What this trial is testing

Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)

Who this might be right for
DepressionDepressive DisorderPoor Metabolizer Due to Cytochrome P450 CYP2D6 Variant+2 more
University of Groningen 202
Not applicableStudy completedNCT02566057
What this trial is testing

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 36
Post-approval studies (Phase 4)UnknownNCT05467436
What this trial is testing

Evaluation of Pharmacogenomics Testing to Precision Prescriptions in Periodontal Patients

Who this might be right for
Oral Surgeries
Augusta University 35
Post-approval studies (Phase 4)UnknownNCT02625155
What this trial is testing

Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens

Who this might be right for
Target Drug-related Adverse Events
InSource Diagnostics 14,000
Not applicableStudy completedNCT03005080
What this trial is testing

Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux
Mayo Clinic 51
Load More Results